Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway
Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated. Methods Here, network pharmacology and molecular d...
Saved in:
Main Authors: | Feifei Li (Author), Youyang Shi (Author), Yang Zhang (Author), Xiaojuan Yang (Author), Yi Wang (Author), Kexin Jiang (Author), Ciyi Hua (Author), Chunyu Wu (Author), Chenping Sun (Author), Yuenong Qin (Author), Sheng Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
Published: (2020) -
Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis
by: Junqing Guo, et al.
Published: (2018) -
Vasculogenic Mimicry in Head and Neck Squamous Cell Carcinoma-Time to Take Notice
by: Abdelhakim Salem, et al.
Published: (2021) -
Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets
by: Haibin Tang, et al.
Published: (2024) -
Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma
by: Qizhi Shuai, et al.
Published: (2024)